Antipsychotics and Metabolic Syndrome

NCT ID: NCT00636753

Last Updated: 2010-07-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

SUSPENDED

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to determine whether antipsychotic treatment is influence psychiatric patients due to endocrine and metabolic status and quality of life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Syndrome

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Metabolic and endocrine changes in schizophrenic patients by antipsychotics treatment.

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

schizophrenic patients

No interventions assigned to this group

2

controls

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Gender male
* Age 18-45
* Debut drug-naive schizophrenics,
* Caucasians
* Consent given to take part in the project

Exclusion Criteria

* Compliance-problems
* Major lung-/kidney/hart/lever disorders
* Abuse of alcohol/drugs
* Diabetes 1 and 2
* Antihypertensive
* Anticholesterol-reducing medication
* Patients under duress
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Glostrup University Hospital, Copenhagen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Psychiatric Center Glostrup

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Psychiatric Center Glostrup

Copenhagen, Nordre Ringvej 28-69, Glostrup, Denmark

Site Status

Psychiatric Center Glostrup

Nordre Ringvej 28-69, Glostrup, Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HC-2007-0070

Identifier Type: -

Identifier Source: org_study_id